6 / 22
Page 66
Notes:
Journal of Clinical & Experimental Pathology | ISSN: 2161-0681 | Volume 8
Breast Pathology and Cancer Diagnosis
6
th
World Congress and Expo on
July 25-26, 2018 | Vancouver, Canada
Medicinal Chemistry and Rational Drugs
20
th
International Conference on
&
The status and potential of Chinese marine materia medica resources
Xiu-Mei Fu
1,2,3
, Meng-Qi Zhang
1,2
and
Chang-Lun Shao
1,2
1
Ocean University of China, China
2
Qingdao National Laboratory for Marine Science and Technology, China
3
Ocean University of China, China
C
hinese marine materia medica (CMMM) is a vital part of traditional Chinese medicine (TCM). Compared with terrestrial
TCM, the CMMM derived from specific marine habitats possesses peculiar chemical components with unique structures
reflecting as potent pharmacological activities, distinct drug properties, and functions. Nowadays, CMMM appears to be
especially effective in treating such difficult diseases as cancers, diabetes, cardio-cerebrovascular diseases, immunodeficiency
diseases and senile dementia and therefore has become an important medicinal resource for the research and development
of new drugs. In recent years, such development has attracted wide attention in the medical field. In this study, the CMMM
resources in China were systematically investigated and evaluated. It was found that the historical experiences of Chinese
people using CMMM have continuously accumulated over a period of more than 3,600 years and that the achievements of the
research on modern CMMM are especially outstanding. By June 2015, 725 kinds of CMMMs from Chinese coastal sea areas
have been identified and recorded, covering 1,552 species of organisms and minerals. More than 3,100 traditional prescriptions
containing CMMS have been imparted and inherited. However, the number of CMMS is less than terrestrial TCM, which
contains 8188 kinds of terrestrial TCM, concerning more than 12100 species of medicinal terrestrial plants, animals, and
minerals. In the future, the research and development of CMMM should focus on the channel entries (TCM drug properties),
compatibility, effective ingredients, acting mechanisms, drug metabolism as well as quality standard. Our study reveals that the
potential of CMMM development is worth expecting.
Biography
Xiu-Mei Fu received his Ph.D. degree in marine medicinal bioresources from Ocean University of China, Qingdao in 2008. From 2000 to 2002, she studied for
environment and resource science as a visiting scholar at University of Duesseldorf, Germany. Since 2006, she is an associate professor of marine medicinal
bioresources at Ocean University of China. She is a member of the Commission of Shandong Oceanology and Limnology Special Committee, China. She has
published more than 40 papers in reputed journals and 3 monographs.
xiumei@ouc.edu.cnXiu-Mei Fu et al, J Clin Exp Pathol 2018, Volume 8
DOI: 10.4172/2161-0681-C3-052